Vessel and Tension-Free Reconstruction During Robot-Assisted Partial Nephrectomy for Hilar Tumors: "Garland" Technique and Midterm Outcomes.

Journal: Journal of endourology
Published Date:

Abstract

Robot-assisted partial nephrectomy (RAPN) is increasingly applied to renal hilar tumors. The present study aims to introduce our vessel and tension-free reconstruction technique and discuss the perioperative, functional, and midterm oncologic outcomes of RAPN for hilar tumors in a large cohort. We retrospectively reviewed clinical data of 286 consecutive patients with hilar tumors who underwent RAPN from June 2013 to December 2016 in our center. Our anatomy-based "Garland" technique specialized in protecting the large hilar vessels and minimizing the tension of suturing the defect via trans/retroperitoneal approaches for anterior/posterior lip hilar tumors, respectively. "Garland" technique was effectively applied in 286 patients, and the warm ischemia time was 18.2 ± 4.1 minutes. Median estimated blood loss for RAPN was 100 mL (interquartile range [IQR]: 50-200 mL). Median operative time was 120 minutes (IQR: 90-150 minutes). No patient was converted to open surgery. Postoperative stay was 4.0 days (IQR: 4.0-5.0 days). Three patients (1.1%) had positive surgical margin. Two patients (0.7%) received blood transfusion. Complications occurred in 20 patients (7.0%), in which 18 patients were Clavien 1 and 2. Three patients (1.1%) had local recurrence. All patients were alive at a 48-month median follow-up (range: 24-66 months). "Garland" technique is safe and feasible for hilar tumor resection and kidney reconstruction. The trans/retroperitoneal approaches are options for anterior/posterior hilar tumors. Longer follow-up involving more patients is required.

Authors

  • Yu Gao
    Department of Radiology Center, The First Affiliated Hospital of Xinxiang Medical University, Xin Xiang, China.
  • Hongzhao Li
    Department of Urology, Chinese People's Liberation Army General Hospital, Beijing, 100039 China.
  • Yuanxin Yao
    Department of Urology, State Key Laboratory of Kidney Diseases, Chinese PLA General Hospital, Beijing, China.
  • Yang Fan
    Colby College, Waterville, Maine, United States of America.
  • Taoping Shi
    Department of Urology, State Key Laboratory of Kidney Diseases, Chinese PLA General Hospital, Beijing, China.
  • Hongkai Yu
    Department of Urology, State Key Laboratory of Kidney Diseases, Chinese PLA General Hospital, Beijing, China.
  • Yongpeng Xie
    Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Baojun Wang
    Department of Urology, State Key Laboratory of Kidney Diseases, Chinese PLA General Hospital, Beijing, China.
  • Xin Ma
    Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Xu Zhang
    China CDC Key Laboratory of Environment and Population Health, National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing 100021, China.